Incisive Genetics
1 known investors
Incisive Genetics is a gene editing company developing therapies for Huntington's disease using allele-selective gene editing combined with a proprietary non-viral lipid nanoparticle (LNP/RNP) delivery platform. Its lead program, IG-HD01, targets the genetic cause of the disease, and the platform is intended to support additional genetic medicine programs.
Investors · 1
Frequently asked questions
- What does Incisive Genetics do?
- Incisive Genetics is a gene editing company developing therapies for Huntington's disease using allele-selective gene editing combined with a proprietary non-viral lipid nanoparticle (LNP/RNP) delivery platform. Its lead program, IG-HD01, targets the genetic cause of the disease, and the platform is intended to support additional genetic medicine programs.
- Who are Incisive Genetics's investors?
- Incisive Genetics's investors include Saltagen Ventures.